Does metformin exposure before ICU stay have any impact on patients’ outcome? A retrospective cohort study of diabetic patients

Abstract Background Impact of metformin exposure before ICU stay remains controversial. Metformin is thought to induce lactic acidosis and haemodynamic instability but may reduce ICU mortality. We evaluated its influence on outcome in diabetic patients admitted in the ICU and then compared two diffe...

Full description

Bibliographic Details
Main Authors: Sebastien Jochmans, Jean-Emmanuel Alphonsine, Jonathan Chelly, Ly Van Phach Vong, Oumar Sy, Nathalie Rolin, Olivier Ellrodt, Mehran Monchi, Christophe Vinsonneau
Format: Article
Language:English
Published: SpringerOpen 2017-12-01
Series:Annals of Intensive Care
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13613-017-0336-8
_version_ 1828486727802552320
author Sebastien Jochmans
Jean-Emmanuel Alphonsine
Jonathan Chelly
Ly Van Phach Vong
Oumar Sy
Nathalie Rolin
Olivier Ellrodt
Mehran Monchi
Christophe Vinsonneau
author_facet Sebastien Jochmans
Jean-Emmanuel Alphonsine
Jonathan Chelly
Ly Van Phach Vong
Oumar Sy
Nathalie Rolin
Olivier Ellrodt
Mehran Monchi
Christophe Vinsonneau
author_sort Sebastien Jochmans
collection DOAJ
description Abstract Background Impact of metformin exposure before ICU stay remains controversial. Metformin is thought to induce lactic acidosis and haemodynamic instability but may reduce ICU mortality. We evaluated its influence on outcome in diabetic patients admitted in the ICU and then compared two different populations based on the presence of septic shock. Methods We conducted a retrospective cohort study in a 24-bed French ICU between October 2010 and December 2013, including all ICU-admitted diabetic patients. Results Among 635 diabetic patients admitted during the study period, 131 (21%) were admitted with septic shock. Multivariate analysis showed no difference in hospital mortality in all metformin users (OR 0.75 [95% CI 0.44–1.28]; p = 0.29), except in the septic shock subgroup (OR 0.61; 95% CI [0.37–0.99]; p = 0.04) despite higher vasopressor dosages in the first hours after shock onset. Blood lactate level was higher in metformin users than in non-metformin users in all patients (p < 0.001), in septic shock patients (p < 0.001) and in patients without kidney injury (p < 0.001). Metformin users did not have more septic shock from unknown aetiology (p = 0.65) or unknown pathogen (p = 0.99). Conclusions Metformin use before admission to ICU did not affect in-hospital mortality. However, for patients with septic shock, mortality was lower, despite worse clinical presentation on admission. Blood lactate levels were always higher with or without septic shock and indifferent of kidney function.
first_indexed 2024-12-11T09:37:26Z
format Article
id doaj.art-86159033dc5e42e5835f76388d3a60c2
institution Directory Open Access Journal
issn 2110-5820
language English
last_indexed 2024-12-11T09:37:26Z
publishDate 2017-12-01
publisher SpringerOpen
record_format Article
series Annals of Intensive Care
spelling doaj.art-86159033dc5e42e5835f76388d3a60c22022-12-22T01:12:47ZengSpringerOpenAnnals of Intensive Care2110-58202017-12-01711910.1186/s13613-017-0336-8Does metformin exposure before ICU stay have any impact on patients’ outcome? A retrospective cohort study of diabetic patientsSebastien Jochmans0Jean-Emmanuel Alphonsine1Jonathan Chelly2Ly Van Phach Vong3Oumar Sy4Nathalie Rolin5Olivier Ellrodt6Mehran Monchi7Christophe Vinsonneau8Département de Médecine Intensive et Unité de Recherche Clinique, Groupe Hospitalier Sud Ile-de-France, Hôpital de MelunService de Réanimation Médicale, AP-HP, Hôpital BicêtreDépartement de Médecine Intensive et Unité de Recherche Clinique, Groupe Hospitalier Sud Ile-de-France, Hôpital de MelunDépartement de Médecine Intensive, Groupe Hospitalier Sud Ile-de-France, Hôpital de MelunDépartement de Médecine Intensive, Groupe Hospitalier Sud Ile-de-France, Hôpital de MelunDépartement de Médecine Intensive, Groupe Hospitalier Sud Ile-de-France, Hôpital de MelunDépartement de Médecine Intensive, Groupe Hospitalier Sud Ile-de-France, Hôpital de MelunDépartement de Médecine Intensive et Unité de Recherche Clinique, Groupe Hospitalier Sud Ile-de-France, Hôpital de MelunService de Réanimation Polyvalente, Hôpital de BethuneAbstract Background Impact of metformin exposure before ICU stay remains controversial. Metformin is thought to induce lactic acidosis and haemodynamic instability but may reduce ICU mortality. We evaluated its influence on outcome in diabetic patients admitted in the ICU and then compared two different populations based on the presence of septic shock. Methods We conducted a retrospective cohort study in a 24-bed French ICU between October 2010 and December 2013, including all ICU-admitted diabetic patients. Results Among 635 diabetic patients admitted during the study period, 131 (21%) were admitted with septic shock. Multivariate analysis showed no difference in hospital mortality in all metformin users (OR 0.75 [95% CI 0.44–1.28]; p = 0.29), except in the septic shock subgroup (OR 0.61; 95% CI [0.37–0.99]; p = 0.04) despite higher vasopressor dosages in the first hours after shock onset. Blood lactate level was higher in metformin users than in non-metformin users in all patients (p < 0.001), in septic shock patients (p < 0.001) and in patients without kidney injury (p < 0.001). Metformin users did not have more septic shock from unknown aetiology (p = 0.65) or unknown pathogen (p = 0.99). Conclusions Metformin use before admission to ICU did not affect in-hospital mortality. However, for patients with septic shock, mortality was lower, despite worse clinical presentation on admission. Blood lactate levels were always higher with or without septic shock and indifferent of kidney function.http://link.springer.com/article/10.1186/s13613-017-0336-8MetforminSeptic shockDiabetesLactic acidosisICU
spellingShingle Sebastien Jochmans
Jean-Emmanuel Alphonsine
Jonathan Chelly
Ly Van Phach Vong
Oumar Sy
Nathalie Rolin
Olivier Ellrodt
Mehran Monchi
Christophe Vinsonneau
Does metformin exposure before ICU stay have any impact on patients’ outcome? A retrospective cohort study of diabetic patients
Annals of Intensive Care
Metformin
Septic shock
Diabetes
Lactic acidosis
ICU
title Does metformin exposure before ICU stay have any impact on patients’ outcome? A retrospective cohort study of diabetic patients
title_full Does metformin exposure before ICU stay have any impact on patients’ outcome? A retrospective cohort study of diabetic patients
title_fullStr Does metformin exposure before ICU stay have any impact on patients’ outcome? A retrospective cohort study of diabetic patients
title_full_unstemmed Does metformin exposure before ICU stay have any impact on patients’ outcome? A retrospective cohort study of diabetic patients
title_short Does metformin exposure before ICU stay have any impact on patients’ outcome? A retrospective cohort study of diabetic patients
title_sort does metformin exposure before icu stay have any impact on patients outcome a retrospective cohort study of diabetic patients
topic Metformin
Septic shock
Diabetes
Lactic acidosis
ICU
url http://link.springer.com/article/10.1186/s13613-017-0336-8
work_keys_str_mv AT sebastienjochmans doesmetforminexposurebeforeicustayhaveanyimpactonpatientsoutcomearetrospectivecohortstudyofdiabeticpatients
AT jeanemmanuelalphonsine doesmetforminexposurebeforeicustayhaveanyimpactonpatientsoutcomearetrospectivecohortstudyofdiabeticpatients
AT jonathanchelly doesmetforminexposurebeforeicustayhaveanyimpactonpatientsoutcomearetrospectivecohortstudyofdiabeticpatients
AT lyvanphachvong doesmetforminexposurebeforeicustayhaveanyimpactonpatientsoutcomearetrospectivecohortstudyofdiabeticpatients
AT oumarsy doesmetforminexposurebeforeicustayhaveanyimpactonpatientsoutcomearetrospectivecohortstudyofdiabeticpatients
AT nathalierolin doesmetforminexposurebeforeicustayhaveanyimpactonpatientsoutcomearetrospectivecohortstudyofdiabeticpatients
AT olivierellrodt doesmetforminexposurebeforeicustayhaveanyimpactonpatientsoutcomearetrospectivecohortstudyofdiabeticpatients
AT mehranmonchi doesmetforminexposurebeforeicustayhaveanyimpactonpatientsoutcomearetrospectivecohortstudyofdiabeticpatients
AT christophevinsonneau doesmetforminexposurebeforeicustayhaveanyimpactonpatientsoutcomearetrospectivecohortstudyofdiabeticpatients